Is a complete PMCB research report available?

No complete published report is available for PharmaCyte Biotech, Inc. (PMCB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · USD

$0.60

+0.01 (+2.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PMCB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.4M
Net income (ttm)	-23.2M
EPS (ttm)	-$2.77
Shares out	10.7M
Volume	628,337
Beta	0.52

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -23.2M
EPS (ttm): -$2.77
Market cap: 6.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PMCB indicators

Market & fundamental data

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001157075
Company name	PharmaCyte Biotech, Inc.
Country	United States
Country code	US
Cusip	71715X203
Employees	2
Employees Change	-2%
Employees Change Percent	-50
Enterprise value	$-30.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US71715X2036
Last refreshed	2026-07-31
Market cap	$6.4M
Market cap category	Nano-Cap
Price	$0.6
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	PMCB
Website	https://pharmacyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-363.3%
P/B ratio	0.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-23.2M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	$-11.6M
Profitable Years	1
ROA	-6.51
Roa5y	-10.95
ROCE	-11.72
ROE	-44.72
Roe5y	-1.35
ROIC	-7.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-38.57%
Cagr15y	-28.19%
Cagr1y	-41.2%
Cagr20y	-27.59%
Cagr3y	-39.65%
Cagr5y	-45.3%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$46.8M
Cash	$37.1M
Current Assets	$20.7M
Current Liabilities	$1.7M
Debt	$0
Equity	$35M
Liabilities	$11.8M
Long Term Assets	$26.1M
Long Term Liabilities	$10.1M
Net Cash	$37.1M
Net Cash By Market Cap	$581
Net Cash Growth	22.57%
Net Debt Equity	$-1.06
Tangible Book Value	$33.7M
Tangible Book Value Per Share	$3.14
WACC	7.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	45.28
Net Working Capital	$-488,779
Quick ratio	45.16
Working Capital	$36.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.58%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.23%
1Y total return	-41.18%
200-day SMA	0.78
3Y total return	-78.02%
50-day SMA	0.72
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.1%
All Time High	1,249.9
All Time High Change	-99.95%
All Time High Date	2003-10-08
All Time Low	0.55
All Time Low Change	9.09%
All Time Low Date	2026-07-30
ATR	0.05
Beta	0.52
Beta1y	1.34
Beta2y	0.79
Ch YTD	-17.13
High	0.62
High52	1.51
High52 Date	2025-12-05
High52ch	-60.26%
Low	0.55
Low52	0.55
Low52 Date	2026-07-30
Low52ch	9.09%
Ma50ch	-16.45%
Premarket Change Percent	-5.5
Premarket Price	$0.55
Premarket Volume	8,102
Price vs 200-day SMA	-23.38%
RSI	36.32
RSI Monthly	33.44
RSI Weekly	38.54
Sharpe ratio	-0.11x
Sortino ratio	-0.13
Total Return	3.58%
Tr YTD	-17.13
Tr15y	-99.3%
Tr1m	-17.92%
Tr1w	-0.79%
Tr3m	-20%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-5.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,960,105%
Float Percent	92.78%
Shares Insiders	6.76%
Shares Institutions	9.26%
Shares Out	10,735,649
Shares Qo Q	36.3%
Shares Yo Y	-3.58%
Short Float	3.24%
Short Ratio	3.49
Short Shares	3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-5,938,643
Average Volume	120,194.5x
Bv Per Share	3.14
Ch10y	-99.23
Ch15y	-99.3
Ch1m	-17.92
Ch1w	-0.79
Ch1y	-41.18
Ch20y	-99.84
Ch3m	-20
Ch3y	-78.02
Ch5y	-95.1
Ch6m	-29.25
Change	2.48%
Change From Open	2.48
Close	0.59
Days Gap	0
Dollar Volume	377,002.2
Earnings Date	2026-09-14
Earnings Time	amc
EBIT	$-5.4M
EBITDA	$-5.4M
EPS	$-2.77
F Score	2
Financing CF	6,581,577
Fiscal Year End	April
Founded	1,996
Investing CF	2,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-17
Last Report Date	2026-01-31
Last Split Date	2021-07-12
Last Split Type	Reverse
Last10k Filing Date	2026-07-29
Ma150	0.74
Ma150ch	-19.28%
Ma20	0.65
Ma20ch	-7.82%
Net CF	3,431,736
Next Earnings Date	2026-08-10
Open	0.59
Optionable	Yes
Position In Range	71.43
Post Close	0.6
Postmarket Change Percent	-2.5
Postmarket Price	$0.59
Pre Close	0.59
Price Date	2026-07-30
Ptbv Ratio	0.19
Relative Volume	5.24x
Share Based Comp	1,128,556
Tr20y	-99.84%
Tr6m	-29.25%
Us State	Nevada
Volume	628,337

PharmaCyte Biotech, Inc. (PMCB)

Coverage state: Market snapshot only — no published research

Generate the first PMCB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · PMCB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PMCB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PMCB

Frequently asked questions